User profiles for DEKEL SHLOMI

Dekel Shlomi

Ariel University
Verified email at ariel.ac.il
Cited by 1503

Diagnostic value of CYFRA 21-1, CEA, CA 19-9, CA 15-3, and CA 125 assays in pleural effusions: analysis of 116 cases and review of the literature

D Shitrit, B Zingerman, ABG Shitrit, D Shlomi… - The …, 2005 - academic.oup.com
Levels of tumor markers in pleural effusions may help to establish the diagnosis of pleural
malignancy, but the precise diagnostic value of each marker remains unclear. The aim of this …

Screening for lung cancer: time for large-scale screening by chest computed tomography

D Shlomi, R Ben-Avi, GR Balmor… - European Respiratory …, 2014 - Eur Respiratory Soc
Lung cancer is the leading cause of cancer death worldwide. Age and smoking are the
primary risk factors for lung cancer. Treatment based on surgical removal in the early stages of …

Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancer

…, VA Miller, D Lipson, GA Palmer, SM Ali, S Dekel… - The …, 2015 - academic.oup.com
Background. The US Food and Drug Administration-approved method for detecting EML4-ALK
rearrangement is fluorescence in situ hybridization (FISH); however, data supporting the …

[HTML][HTML] The association of OSA with insulin resistance, inflammation and metabolic syndrome

N Peled, M Kassirer, D Shitrit, Y Kogan, D Shlomi… - Respiratory …, 2007 - Elsevier
Obstructive sleep apnea (OSA) shares many cardiovascular risk factors with metabolic
syndrome, including obesity, hypertension, insulin resistance, and pro-inflammatory state. This …

[HTML][HTML] Exhaled breath analysis for monitoring response to treatment in advanced lung cancer

…, N Gai-Mor, M Ilouze, A Onn, J Bar, D Shlomi… - Journal of Thoracic …, 2016 - Elsevier
Introduction The Response Evaluation Criteria in Solid Tumors (RECIST) serve as the
accepted standard to monitor treatment efficacy in lung cancer. However, the time intervals …

[HTML][HTML] Detection of lung cancer and EGFR mutation by electronic nose system

D Shlomi, M Abud, O Liran, J Bar, N Gai-Mor… - Journal of Thoracic …, 2017 - Elsevier
Introduction Early detection of lung cancer (LC) has been well established as a significant
key point in patient survival and prognosis. New highly sensitive nanoarray sensors for …

Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension

N Peled, D Shitrit, BD Fox, D Shlomi, A Amital… - The Journal of …, 2009 - jrheum.org
Objective. Pulmonary endothelial dysfunction and increased reflection of pulmonary
pressure waves have been reported in pulmonary arterial hypertension (PAH). However, the …

Increased risk for cancer in young patients with severe obstructive sleep apnea

…, B Silverman, I Liphsitz, T Kolitz, C Levy, D Shlomi… - Respiration, 2018 - karger.com
Background: Several studies in animal models and human with obstructive sleep apnea
syndrome (OSAS) demonstrated an increase in cancer aggressiveness and mortality. However, …

Pulmonary Mycobacterium kansasii infection in Israel, 1999–2004: clinical features, drug susceptibility, and outcome

…, R Priess, A Lavy, ABG Shitrit, M Raz, D Shlomi… - Chest, 2006 - Elsevier
Background: Mycobacterium kansasii infection is one of the most common causes of
nontuberculous mycobacterial lung disease in world. However, little is known about its background …

Use of Amplatzer device for endobronchial closure of bronchopleural fistulas

…, N Peled, D Shitrit, E Atar, M Saute, D Shlomi… - Chest, 2008 - Elsevier
Bronchopulmonary fistula (BPF) is associated with high morbidity and mortality. It occurs as
an uncommon but often severe complication of pneumonectomy. BPF may be treated by a …